The FDA has renewed and expanded its real-world cancer data collaboration with Flatiron Health for another two years, to continue its work into the validation of related clinical endpoints and development of real-world control arms....
Roche and Flatiron Health, Inc. announced that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health.